Evidence map›Paper›PMID 34015528›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway.

Eric Guedj, Françoise Lazarini, Silvia Morbelli, Mathieu Ceccaldi, Charlotte Hautefort, Aurélie Kas, Thomas Radulesco, Dominique Salmon-Ceron, Carole Eldin

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Brain Metabolic PET Findings on the Long-Term Effects of COVID-19.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Eric GuedjAix Marseille Université, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Marseille, France. Electronic address: eric.guedj@ap-hm.fr.
Françoise LazariniInstitut Pasteur, Perception and Memory Unit, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 3571, Paris, France.
Silvia MorbelliIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Mathieu CeccaldiAix Marseille Université, INSERM, Inst Neurosci Syst, & APHM, Service de Neurologie et de Neuropsychologie, CHU Timone, Marseille, France.
Charlotte HautefortDepartment of Otorhinolaryngology, Lariboisière Hospital, Assistance Publique - Hôpitaux de Paris, INSERM U1141, Université de Paris, Paris, France.
Aurélie KasAPHP Sorbonne Université, Nuclear Medicine Department, CNRS, INSERM, LIB, Paris, France.
Thomas RadulescoAix-Marseille Université, APHM, IUSTI, La Conception University Hospital, Department of Oto-Rhino-Laryngology Head and Neck Surgery, Marseille, France.
Dominique Salmon-CeronDepartment of Infectious Medicine and Immunology, Hotel Dieu Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris, Paris, France.
Carole EldinAix Marseille Université, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France.
Aix-Marseille Université · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur · FROspedale Policlinico San Martino · ITUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Fluorodeoxyglucose F18HumansMemory DisordersOlfaction DisordersOlfactory BulbPositron-Emission TomographyPost-Acute COVID-19 SyndromeRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals[(18)F]fluorodeoxyglucoseAnosmiaComplaintsCoronavirus disease 2019EmotionMemoryOlfactionPositron emission tomographyRehabilitationSevere acute respiratory syndrome coronavirus 2

Identifiers

PMID34015528
PMCPMC8164472
OpenAlexW3161270745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.